ABBOTT LABORATORIES — Director's Dealing 2007

Feb 20, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-15

Reporting Person: Chen Thomas F (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-15	Common shares without par value	F	7101	$52.70	Disposed	70420	Direct
2007-02-16	Common shares without par value	A	20400	$52.54	Acquired	90820	Direct
2007-02-16	Common shares without par value	A	17000	$52.54	Acquired	107820	Direct
2007-02-17	Common shares without par value	F	1644	$52.49	Disposed	106176	Direct
2007-02-18	Common shares without par value	F	684	$52.49	Disposed	105492	Direct
2007-02-20	Common shares without par value	F	1776	$52.49	Disposed	103716	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-16	Option (right to buy)	$52.54	A	83000	Acquired	2017-02-15	common shares (83000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17129	Indirect
Common shares without par value	23798	Indirect
Common shares without par value	2476	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2007.

F4: The reporting person disclaims beneficial ownership of all securities held by his wife and daughter.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009, and 27,666 on 02/16/2010.